N-Cbz-Lysine T-Butyl Ester Bulk Price | Global Manufacturer
Procurement teams and R&D chemists frequently face challenges securing consistent industrial purity for protected amino acids. Variability in optical rotation and unexpected impurity profiles can derail peptide synthesis campaigns, making the selection of a reliable global manufacturer critical for project continuity.
Troubleshooting common impurities and yield issues
When sourcing Cbz-Lys-OtBu HCl, the presence of trace impurities can significantly impact downstream coupling efficiency. The most prevalent issue encountered in lower-grade batches is racemization at the alpha-carbon during the protection or esterification stages. This loss of chiral integrity is often undetectable without rigorous chiral HPLC analysis but results in diastereomeric peptides that are difficult to purify. Manufacturers must maintain strict temperature control during the benzyloxycarbonylation step to preserve stereochemistry.
Racemization Risks During Esterification
The formation of the tert-butyl ester requires acidic conditions that can inadvertently promote epimerization if reaction times are prolonged. High-quality production protocols utilize mild acid catalysts and monitor reaction progress via TLC or in-process HPLC to quench the reaction immediately upon completion. Procurement specialists should request historical batch data regarding optical rotation values to verify that the supplier maintains enantiomeric excess above 99.0%.
Di-Protection and Selectivity Errors
Another common defect involves the formation of N-alpha,N-epsilon-di-Cbz protected species. Since lysine contains two amino groups, selective protection of the alpha-amine is paramount. Inadequate pH control during the Schotten-Baumann reaction can lead to over-protection. This impurity complicates subsequent deprotection steps, as the epsilon-Cbz group requires harsher conditions to remove than the tert-butyl ester, potentially damaging the peptide backbone.
Furthermore, residual solvents and heavy metals from catalysts used in the hydrogenation or protection steps must be minimized. A robust Lysine Building Block supply chain ensures that every batch undergoes thorough drying and purification via recrystallization. Understanding these failure modes allows procurement officers to specify tighter acceptance criteria in their purchase agreements, ensuring that the material meets the stringent requirements of solid-phase peptide synthesis.
Detailed chemical synthesis route and reaction mechanism
The production of this protected amino acid begins with L-lysine hydrochloride, which undergoes selective protection. The alpha-amino group is protected using benzyl chloroformate (Cbz-Cl) under controlled alkaline conditions. This step requires precise stoichiometry to prevent reaction at the epsilon-amino group. Following isolation, the carboxylic acid is esterified using isobutylene in the presence of a strong acid catalyst, such as sulfuric acid or p-toluenesulfonic acid, to form the tert-butyl ester.
For a deeper understanding of the reaction kinetics and scale-up parameters, refer to our technical analysis on Cbz-Lys-Otbu Hcl Synthesis Route Industrial Purity. The mechanism involves the protonation of the carboxylate followed by nucleophilic attack by the tert-butyl cation generated from isobutylene. This method is preferred over using tert-butanol because it drives the equilibrium towards ester formation more effectively, resulting in higher yields and fewer side products.
Scale-up production introduces thermal management challenges that are not present in laboratory settings. Large-scale reactors require efficient cooling systems to manage the exothermic nature of the esterification reaction. N'-Cbz-L-lysine tert-butyl ester hydrochloride produced at an industrial scale must maintain the same purity profile as lab-grade material. This is achieved through iterative process validation and strict adherence to standard operating procedures during crystallization and drying phases.
Final conversion to the hydrochloride salt ensures stability during storage and handling. The salt form improves solubility in common peptide coupling solvents like DMF and DCM. Manufacturers should provide detailed synthesis documentation to clients engaged in custom synthesis projects, ensuring transparency regarding reagents and potential carryover impurities. This level of detail supports regulatory filings and quality audits for pharmaceutical applications.
Technical specifications and analytical methods
Quality assurance relies on comprehensive analytical testing protocols. Every batch must be verified against strict specifications for appearance, identity, assay, and impurities. High-Performance Liquid Chromatography (HPLC) is the primary method for determining chemical purity, while Nuclear Magnetic Resonance (NMR) spectroscopy confirms the structural integrity of the protecting groups. Loss on drying tests ensure that moisture content is minimized to prevent hydrolysis during storage.
Compatibility with various synthesis strategies is also a key consideration. For insights into how this material performs in complex sequences, review our article on Protected Lysine Derivative Spps Formulation Compatibility. Analytical methods must be validated to detect specific known impurities such as the di-Cbz species or the free acid form. Third-party testing by agencies like SGS or Intertek is often accepted under required conditions to provide an additional layer of verification for international buyers.
| Parameter | Specification | Test Method |
|---|---|---|
| Appearance | White to Off-White Crystalline Powder | Visual Inspection |
| Assay (HPLC) | ≥ 98.5% | Area Normalization |
| Optical Rotation | -15.0° to -17.0° (c=1, H2O) | Polarimetry |
| Loss on Drying | ≤ 0.5% | Karl Fischer / LOD |
| Heavy Metals | ≤ 10 ppm | ICP-MS |
Verification of the Certificate of Analysis (COA) is a critical step for procurement teams. The COA should match the batch number on the packaging and include chromatograms supporting the purity claims. Discrepancies in retention times or peak areas should be investigated immediately. Consistent analytical data across multiple batches indicates a stable manufacturing process, which is essential for long-term production planning.
Factory-direct bulk pricing advantages and supply chain stability
Securing a competitive bulk price requires partnering with a manufacturer that controls the entire production lifecycle. NINGBO INNO PHARMCHEM CO.,LTD. leverages strategic manufacturing bases to optimize production costs without compromising quality. By managing raw material sourcing and synthesis in-house, we eliminate intermediary markups, passing cost savings directly to the client. This vertical integration also allows for greater flexibility in adjusting production schedules to meet urgent demand.
Supply chain stability is reinforced by a strong quality control system based on ISO standards. QA and QC are used in the whole process of raw material control, process control, and finished product quality inspection. This ethical commitment to quality assurance ensures that every shipment meets the agreed specifications. Flexible payment terms such as L/C, D/P, and T/T are accepted to facilitate smooth international transactions, though customers should never remit payment to personal accounts.
Logistics and delivery time are managed by an experienced sales team with global reach. We provide different quantities of custom synthesis chemicals in lab, plant, and industrial scale. Whether you require kilogram quantities for pilot studies or metric tons for commercial production, the supply chain is designed to scale accordingly. Inventory management systems track stock levels in real-time to prevent shortages of critical Protected Lysine Derivative inventory.
Ultimately, the value proposition extends beyond price to include technical support and regulatory compliance. Our R&D center offers custom synthesis services to modify standard protocols for specific client needs. This collaborative approach ensures that the material fits seamlessly into your existing workflows. Reliability in delivery and consistency in quality are the hallmarks of a true partner in the chemical industry.
Investing in high-quality building blocks reduces the risk of failed batches in downstream peptide synthesis. By choosing a manufacturer with robust testing capabilities and transparent communication, organizations can safeguard their production timelines. The combination of technical expertise and supply chain resilience ensures that projects proceed without interruption due to material shortages or quality failures.
To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.